The late breaking abstract submission for CINP 2026 is now open! Don't miss the last chance to share your work with a global audience of renowned experts in neuropsychopharmacology and join us in Glasgow from June 26th to June 29th, 2026. You can still submit your abstract for a Featured Communication (Oral Presentation 15 min), Data Blitz (Oral Presentation 6 min) or Poster. Check all details and submission criteria on the congress website and don't hesitate to contact the Congress Secretariat in case you have any questions. Deadline for submission: February 24, 2026. |
We are proud to announce that CINP 2026 will collaborate with Glasgow Children’s Hospital Charity to support the National Child Psychiatry Unit (Ward 4) at the Royal Hospital for Children in Glasgow. Ward 4 is the only unit of its kind in Scotland, caring for children under 12 from across the country. Many patients stay for months at a time, making safe, supportive, and creative environments essential to their care and wellbeing. During CINP 2026, the Charity will also host a charity shop at the congress venue, where participants can support this important work by purchasing merchandise and souvenirs and learn more about the charity activities. Join us in Glasgow and be part of something meaningful - together, we can support children, families, and clinical teams when it matters most. |
Introducing CINP 2026 Keynote Speaker: Professor Marion Leboyer (France) Professor Marion Leboyer is Professor of Psychiatry at the University of Paris Est Créteil and a recognised leader in translational and precision psychiatry. She leads major national and international research initiatives focused on identifying biological, genetic, and immune mechanisms in severe psychiatric disorders. As Executive Director of Fondation FondaMental, she has helped establish large longitudinal patient cohorts and collaborative research networks that are shaping the future of precision psychiatry. Her keynote lecture at CINP 2026 in Glasgow will be: Towards precision psychiatry: the example of immune dysfunctions in major psychiatric disorders |
Introducing CINP 2026 Keynote Speaker: Professor Ole Andreassen (Norway) Professor Ole Andreassen is Professor of Psychiatry at the University of Oslo and Director of the Centre for Precision Psychiatry. His work combines clinical, neurocognitive, brain imaging, and genetic approaches — including AI-based tools — to advance precision psychiatry. He chairs international consortia within the Psychiatric Genetics Consortium and ENIGMA, coordinates major European research projects, and is widely recognised for his scientific contributions. At CINP 2026 in Glasgow, Professor Andreassen will present a keynote lecture: Genetics of psychiatric disorders - from discoveries to clinical translation |
We are excited to announce the preparation of an International Course in Psychopharmacology, designed for residents in psychiatry and neurology, psychiatrists, neurologists, and general practitioners, and everybody who wishes to deepen their understanding of the mechanisms and clinical applications of psychopharmacological treatments. Through this program, CINP seeks to foster global learning, professional development, and the dissemination of evidence-based neuropsychopharmacology. The course will be online, CME-accredited, with sessions held every Thursday for several consecutive weeks. The first edition of the course is planned for the second half of 2026. More information coming soon! |
Introducing CINP 2026 Keynote Speakers: Professor Barbara J. Sahakian (UK) Professor Barbara Sahakian is an internationally renowned leader in psychiatric neuroscience, with a distinguished career spanning psychopharmacology, neuropsychology, neuroethics, and public policy. Based at the University of Cambridge, her work has had a lasting impact on how we understand brain health, cognition, and mental health across the lifespan. Her keynote lecture at CINP 2026 in Glasgow will be: Psychiatric Neuroscience: Improving Brain Health, Cognition and Mental Health |
GLOBAL
| International Journal of Neuropsychopharmacology
Impact Factor: 3.7 |
-
January 30, 2026 10:48
-
December 17, 2025 15:46
-
October 27, 2025 16:13
